aurintricarboxylic acid and efavirenz

aurintricarboxylic acid has been researched along with efavirenz in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kang, X; Kollman, PA; Kuntz, ID; Wang, J	1
Blair, WS; Butler, SL; Cao, J; Chu, A; Graham, J; Isaacson, J; Jackson, L; Jimenez, J; Malfait, AM; Patick, AK; Peng, Q; Tortorella, M; Wu, H	1

Other Studies

2 other study(ies) available for aurintricarboxylic acid and efavirenz

Article	Year
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA. Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7 Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics	2005
Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Alkynes; Anti-HIV Agents; Benzeneacetamides; Benzoxazines; Blotting, Western; Cyclopropanes; Cytopathogenic Effect, Viral; DNA, Recombinant; Drug Resistance, Bacterial; HeLa Cells; HIV Core Protein p24; HIV Envelope Protein gp160; HIV-1; Humans; Piperidines; Protein Processing, Post-Translational; Virus Replication	2007

Article

Year

Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.

Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7

Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics

2005

Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.

Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

Topics: Alkynes; Anti-HIV Agents; Benzeneacetamides; Benzoxazines; Blotting, Western; Cyclopropanes; Cytopathogenic Effect, Viral; DNA, Recombinant; Drug Resistance, Bacterial; HeLa Cells; HIV Core Protein p24; HIV Envelope Protein gp160; HIV-1; Humans; Piperidines; Protein Processing, Post-Translational; Virus Replication

2007